The group reviews the July 2019 issue of Retinal Physician, focusing on ocular oncology with Drs. Basil Williams and Ajay Kuriyan.
Relevant Financial Disclosures: Dr. Williams has no financial disclosures. Dr. Sridhar has received fees for consulting for Alimera, Alcon and Thrombogenics. Dr. Kuriyan is a consultant for Allergan, Alimera Sciences, Regeneron and Valeant, and receives grant funding from Roche/Genentech and Second Sight.
Release: July 01, 2019; expires July 01, 2022
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.